Innovating cancer care access for low and middle-income countries
Prof Laila Hessissen speaks to ecancer at the 2019 AORTIC conference in Maputo about the existing gap between low- and middle-income countries (LMICS) and high-income countries in regards to the care and outcomes of paediatric patients.
She mentions that this gap is mostly attributed to the lack of adequate paediatric facilities to accurately diagnose and treat these patients.
Prof Hessissen also discusses what can be done to address this gap, but emphasises the need for government involvement to achieve this.
Innovating cancer care access for low and middle-income countries
Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations
Prostate cancer
Rectal cancer
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres
Time toxicity: the burden on cancer patients